Series A - City Therapeutics - 2024-10-08 - Crunchbase
City Therapeutics raised $135000000 on 2024-10-08 in Series A. ARCH Venture Partners ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
OFF
Series A - City Therapeutics - 2024-10-08 - Crunchbase
1 day from now
City Therapeutics raised $135000000 on 2024-10-08 in Series A. ARCH Venture Partners ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
crunchbase.com
OFF
City Therapeutics Launches With $135 Million Series A Financing To …
1 day from now
Oct 8, 2024 · City Therapeutics is building a pipeline of innovative RNAi therapeutics, with its lead program expected to enter clinical development at or around the end of 2025.
businesswire.com
OFF
City Therapeutics Launches With $135 Million Series A Financing To …
1 day from now
Oct 8, 2024 · Harnessing next-generation siRNA engineering to improve and expand the therapeutic reach of RNAi-based medicines Building sustainable product engine for innovative …
citytx.com
OFF
City Therapeutics Raises $135M In Series A Financing
1 day from now
Oct 8, 2024 · City Therapeutics, a Cambridge, MA-based biopharmaceutical company which specializes in RNA interference (RNAi)-based medicine, raised $135M in Series A funding.. …
finsmes.com
OFF
City Therapeutics Launches With $135m Series A Funding - Yahoo …
1 day from now
Oct 9, 2024 · City Therapeutics launches with $135m Series A funding. ... "City Therapeutics launches with $135m Series A ... conducted a 10-for-1 stock split following the market close …
yahoo.com
OFF
City Therapeutics Debuts With $135M Series A To Revolutionize …
1 day from now
Nov 18, 2024 · City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics ... engineering of small interfering RNAs (siRNAs), has officially launched, …
bio-itworld.com
OFF
City Therapeutics Announces Launch With $135M Series A Financing
1 day from now
Gunderson Dettmer represented client City Therapeutics in its $135 million Series A financing led by ARCH. City Therapeutics aims to harness next-generation engineering of small interfering …
gunder.com
OFF
City Therapeutics Launches With $135 Million Series A ... - BioSpace
1 day from now
Oct 8, 2024 · City Therapeutics is building a pipeline of innovative RNAi therapeutics, with its lead program expected to enter clinical development at or around the end of 2025. Thereafter, the …
biospace.com
OFF
City Therapeutics Company Profile 2024: Valuation, Funding
1 day from now
Oct 8, 2024 · Early Stage VC (Series A) 08-Oct-2024: $135M: Completed: Startup: 1. Seed Round: Completed: Startup: ... How much funding has City Therapeutics raised over time? …
pitchbook.com
OFF
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based …
1 day from now
City Therapeutics announced its launch with a vision to lead the future of RNA interference (RNAi)-based medicine. And City Therapeutics aims to utilize next-generation engineering of …
pulse2.com
OFF
City Therapeutics Launches With $135 Million Series A Financing To …
1 day from now
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine. ... October 8, 2024-- City Therapeutics, Inc. announced its launch today with …
vcaonline.com
OFF
Series A - Kailera Therapeutics - 2024-10-01 - Crunchbase
1 day from now
Oct 1, 2024 · Kailera Therapeutics raised $400000000 on 2024-10-01 in Series A. Bain Capital Life Sciences Bain Capital Life Sciences specializes in buyouts, inflection capital, growth …
crunchbase.com
OFF
Among Biggest Startup Funding States, California Gains While ...
1 day from now
6 days ago · This includes a $405 million Series F for battery technology company Form Energy and a $400 million Series A for obesity drug developer Kailera Therapeutics. Texas also looks …
crunchbase.com
OFF
Series A - Xaira Therapeutics - 2024-04-23 - Crunchbase
1 day from now
Apr 23, 2024 · Xaira Therapeutics raised $1000000000 on 2024-04-23 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. ... Xaira Therapeutics Launches with $1 …
crunchbase.com
OFF
Series A - Doron Therapeutics - 2024-11-25 - Crunchbase
1 day from now
3 days ago · Doron Therapeutics raised $11000000 on 2024-11-25 in Series A. Search Crunchbase. Start Free Trial ... Overview. Edit Overview Section. Organization Name . Doron …
crunchbase.com
OFF
Series A - Arda Therapeutics - 2024-10-01 - Crunchbase Funding …
1 day from now
Arda Therapeutics raised $43000000 on 2024-10-01 in Series A. Search Crunchbase. Start Free Trial ... Arda Therapeutics . Announced Date Oct 1, 2024; Closed On Date Oct 9, 2024; …
crunchbase.com
FAQs about Series A - City Therapeutics - 2024-10-08 - Crunchbase Coupon?
Who owns City Therapeutics?
Can city Therapeutics lead this next chapter?
Where is city Therapeutics located?
Why did corner Therapeutics close a series a?
What does city Therapeutics do?
When will city Therapeutics start developing RNAi-based medicines?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
